The most common adverse events are gastrointestinal: nausea (occurring in 12-33% of subjects depending on dose), diarrhea, constipation, and decreased appetite
The FDA has classified BPC-157 in Category 2 for bulk drug substances, citing possible safety issues in compounding, such as immunogenicity, impurities, and insufficient safety evidence for suggested administration routes
Vitamin B12 (cobalamin) is a water-soluble vitamin essential for neurological function, DNA synthesis, and red blood cell formation
JFVIT B12 by Jfrin Pharmaceuticals is a veterinary vitamin supplement containing Vitamin B12 (Cyanocobalamin 250 mcg/ml), essential for supporting overall health, growth, and metabolic functions in
No adverse effects were noted in clinical trials (ulcerative colitis, phase II) [84,85], and in toxicological studies, a lethal dose (LD1) was not achieved (for review, see [11,12,13,14,24,25])
Journal of Neurochemistry, 151(2), 135-149